loader from loading.io

Side Chat: 360 with Jeffrey Fudin

PPM Side Chats & Case Chats

Release Date: 06/30/2021

Side Chat: 360 with Jeffrey Fudin show art Side Chat: 360 with Jeffrey Fudin

PPM Side Chats & Case Chats

PPM Editor-at-Large Jeff Gudin, MD, interviews his long-term colleague, co-editor, and friend, Jeffrey Fudin, about what his recent diagnosis has taught him about opioids, patient care, and the field of clinical pharmacy as it stands in pain management. The duo discuss everything from Dr. Fudin’s early career in “hemonc” to how pharmacists are trained today, the pipeline analgesics and alternative therapies they are most excited about, the need for patient navigators in pain medicine, and what future clinicians need to know.   (30 minutes, June 30, 2021)

info_outline
Evolving Treatments for Chronic Headache and Migraine show art Evolving Treatments for Chronic Headache and Migraine

PPM Side Chats & Case Chats

In PPM's new Case Chat series, neurologist Charles Argoff, MD, and anesthesiologist/pain fellow Ben Portal, MD, use a recent chronic headache case to discuss how treatment approaches have evolved, including primary care assessment tools and multitherapy use. Moderated by PPM Co-Editors-at-Large Jeff Gudin, MD, and Jeffrey Fudin, PharmD, FCCP, FASHP. (May 2021, 22 minutes)

info_outline
20/20 Side Chat with Mark Wallace MD show art 20/20 Side Chat with Mark Wallace MD

PPM Side Chats & Case Chats

A conversation with the pain management community’s go-to – Mark Wallace, MD, of UC San Diego – on questions surrounding cannabis effects, safety, formulations, and promise as a therapeutic tool. Plus, why he feels medical marijuana should be offered to patients before opioids. (November 2020)

info_outline
20/20 with Drs. Carmen R. Green and Johnathan Goree: Racial Disparities in Pain Care show art 20/20 with Drs. Carmen R. Green and Johnathan Goree: Racial Disparities in Pain Care

PPM Side Chats & Case Chats

A conversation on provider bias, a history of suboptimal care, and why telemedicine may be further hindering healthcare access for minority patients. (September 2020)

info_outline
20/20 Side Chat with Nathaniel Katz, MD show art 20/20 Side Chat with Nathaniel Katz, MD

PPM Side Chats & Case Chats

A conversation with Nathaniel Katz, MD, of Analgesic Solutions, on clinical trial research and the future of pain therapeutics, including the use of patients as measurement instruments, and why we need to remember the history of opioid use and the purpose of rational management to make real progress. (July 2020)

info_outline
20/20 with Suzanne Amato Nesbit, PharmD, FCCP, BCPS, CPE show art 20/20 with Suzanne Amato Nesbit, PharmD, FCCP, BCPS, CPE

PPM Side Chats & Case Chats

Clinical pharmacist and pain specialist Suzanne Amato Nesbit, PharmD, FCCP, BCPS, CPE, shares her take on the evolving state of pain medicine, including a look at the role of physicians and community pharmacists in opioid stabilization, how young trainees should incorporate addiction medicine into their studies, and how the COVID-19 pandemic is revealing clinical disparities in an already vulnerable patient population. (May 2020)

info_outline
20/20 with Peter Staats, MD, MBA show art 20/20 with Peter Staats, MD, MBA

PPM Side Chats & Case Chats

President-Elect of the World Institute of Pain, Peter Staats, MD, MBA, shares his 20/20 vision on the evolution of the pain management field, from previously unimaginable advancements in neuromodulation, such as vagus nerve stimulation, to what future pain specialists need to know about their patients, collaboration, and money. (April 2020)

info_outline
20/20 with Lynn Webster, MD show art 20/20 with Lynn Webster, MD

PPM Side Chats & Case Chats

Developer of the Opioid Risk Tool and past president of AAPM, shares his 20/20 vision on the evolution of pain medicine, from the beginning of pain management as a specialty to a future where digital medicine and behavioral support may lead the way. (February 2020)

info_outline
 
More Episodes

PPM Editor-at-Large Jeff Gudin, MD, interviews his long-term colleague, co-editor, and friend, Jeffrey Fudin, about what his recent diagnosis has taught him about opioids, patient care, and the field of clinical pharmacy as it stands in pain management. The duo discuss everything from Dr. Fudin’s early career in “hemonc” to how pharmacists are trained today, the pipeline analgesics and alternative therapies they are most excited about, the need for patient navigators in pain medicine, and what future clinicians need to know.

 

(30 minutes, June 30, 2021)